Download PDF
A global team of researchers has announced clinical trial results that point to a new immunotherapy treatment option for two of the most common types of soft tissue sarcoma in adults.
This month: Nephrotic syndrome
Best new tech this month
Scientists have developed a powerful predictive model for identifying the most potent cancer-killing immune cells for use in cancer immunotherapies.
